GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GlaxoSmithKline
Nine COVID-19 vaccine makers sign safety pledge
The companies said in a statement they would uphold the integrity of the scientific process as they work towards potential global…
GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma
BLENREP is the fifth major medicine approval for GSK in 2020
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production
The approval granted through a business review letter from the Justice Department's antitrust division, however, has not allowed…
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal: report
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year,…
US FDA approves GSK’s HIV drug for patients with limited options
The oral treatment from the company’s HIV unit, ViiV Healthcare, has been approved for adults whose HIV infection could not be…
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be…
Gavi to award $75 million to Serum Institute of India for introduction of the pneumonia vaccine in…
Until now, the only two producers of the pneumonia vaccine have been Pfizer and GlaxoSmithKline (GSK)
GSK reports revenue growth at 3 per cent in quarter financial results
Board of Directors of the Company recommends a Dividend of Rs. 40 per equity share (including special dividend of Rs. 20 per…
GSK’s long-acting injection beats Truvada in HIV prevention trial
Truvada generated $2.8 billion in sales last year, both from treatment and preventing an HIV infection